Ashfield Capital Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$224K Hold
1,267
0.02% 215
2022
Q2
$259K Sell
1,267
-168
-12% -$35.6K 0.02% 212
2022
Q1
$341K Hold
1,435
0.02% 209
2021
Q4
$328K Hold
1,435
0.02% 212
2021
Q3
$278K Hold
1,435
0.02% 219
2021
Q2
$305K Hold
1,435
0.02% 215
2021
Q1
$293K Hold
1,435
0.02% 213
2020
Q4
$261K Hold
1,435
0.02% 215
2020
Q3
$240K Hold
1,435
0.02% 208
2020
Q2
$233K Hold
1,435
0.02% 203
2020
Q1
$248K Hold
1,435
0.03% 197
2019
Q4
$288K Hold
1,435
0.03% 211
2019
Q3
$303K Hold
1,435
0.03% 208
2019
Q2
$279K Hold
1,435
0.03% 221
2019
Q1
$236K Hold
1,435
0.03% 233
2018
Q4
$270K Hold
1,435
0.04% 216
2018
Q3
$244K Hold
1,435
0.03% 232
2018
Q2
$235K Hold
1,435
0.03% 239
2018
Q1
$232K Hold
1,435
0.03% 235
2017
Q4
$210K Buy
+1,435
New +$204K 0.03% 245
2017
Q3
Sell
-1,645
Closed -$206K 250
2017
Q2
$206K Buy
+1,645
New +$197K 0.03% 247
2013
Q4
Sell
-5,545
Closed -$410K 250
2013
Q3
$410K Buy
+5,545
New +$409K 0.02% 199

Other funds holding CME

Ashfield Capital Partners's CME Position: Q3 2022 in Review

Ashfield Capital Partners held its CME Group (CME) position steady in Q3 2022 at 1,267 shares worth $224K. The position accounts for 0.02% of the portfolio, ranked #215.

Ashfield Capital Partners first reported a position in CME in Q3 2013 and has held it in 22 quarters since. The position peaked at $410K in Q3 2013. 1,145 funds tracked by Wall St. Rank hold CME as of Q3 2022.

  • Ashfield Capital Partners held 1,267 shares of CME Group worth $224K as of Q3 2022.
  • Ashfield Capital Partners left its CME Group share count unchanged in Q3 2022.
  • CME Group made up 0.02% of Ashfield Capital Partners's portfolio in Q3 2022, its #215 holding.
  • Ashfield Capital Partners first reported a position in CME Group in Q3 2013 and has held it in 22 quarters since.
  • Ashfield Capital Partners's CME Group position peaked at $410K in Q3 2013.
  • 1,145 funds tracked by Wall St. Rank held CME Group as of Q3 2022.

Based on Ashfield Capital Partners's 13F filing for Q3 2022, filed 10 Nov 2022.